Publication: Use of Zoledronic Acid in the Treatment of Paget's Disease
Open/View Files
Date
2007
Published Version
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Dove Medical Press
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Seton, Margaret, and Stephen M. Krane. 2007. Use of zoledronic acid in the treatment of Paget's disease. Therapeutics and Clinical Risk Management 3(5): 913-918.
Research Data
Abstract
This review examines the use of zoledronic acid in the treatment of Paget’s disease of bone. It begins with a brief discussion of the theories of pathogenesis of Paget’s disease, its clinical manifestations, and the history of bisphosphonate treatment in this disorder. Risk of oversuppression of bone by the more potent bisphosphonates and their association with avascular necrosis of the jaw are noted.
Description
Other Available Sources
Keywords
Paget’s disease of bone, bisphosphonates, zoledronic acid
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service